Literature DB >> 16544281

Proteomic analysis of plasma from patients with systemic lupus erythematosus: increased presence of haptoglobin alpha2 polypeptide chains over the alpha1 isoforms.

Esther J Pavón1, Pilar Muñoz, Antonio Lario, Victoria Longobardo, Montserrat Carrascal, Joaquín Abián, Ana B Martin, Salvador A Arias, José-Luis Callejas-Rubio, Ricardo Sola, Francisco Navarro-Pelayo, Enrique Raya-Alvarez, Norberto Ortego-Centeno, Mercedes Zubiaur, Jaime Sancho.   

Abstract

In the present study plasma samples from 15 systemic lupus erythematosus (SLE) patients and 16 healthy controls of initially unknown haptoglobin (Hp) phenotype were separated by 2-DE, and tryptic digests of the excised Hpalpha polypeptide chain spots were analyzed by MALDI-TOF-MS. Selected tryptic peptides were sequenced by nano-(n)ESI-IT MS/MS. The six major Hp phenotypes were present, although with distinct frequencies in controls and SLE patients. Thus, there were an increased proportion of SLE patients with Hp 2-2, or Hp 2-1S phenotypes. The Hp phenotype distribution resulted in allele frequencies of 0 625 (Hp(2)), 0.281 (Hp(1S)), and 0.093 (Hp(1F)) in healthy controls, correlating fairly well with the allele frequencies of European populations. In contrast, the Hp allele frequencies of the SLE patients were 0.733 (Hp(2)), 0.233 (Hp(1S)), and 0.033 (Hp1(1F)), which clearly indicated an increased frequency of Hp(2), a similar proportion of Hp(1S) and a diminished proportion of Hp(1F) in SLE patients compared with that in healthy controls. Preferential Hpalpha2 expression in SLE patients may contribute to some of the clinical manifestations of the disease such as hypergammaglobulinemia, systemic vasculitis, and cardiovascular disorders.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16544281     DOI: 10.1002/pmic.200500404

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  14 in total

Review 1.  The role of Haptoglobin and its related protein, Zonulin, in inflammatory bowel disease.

Authors:  Tim Vanuytsel; Séverine Vermeire; Isabelle Cleynen
Journal:  Tissue Barriers       Date:  2013-12-10

2.  Urinary haptoglobin, alpha-1 anti-chymotrypsin and retinol binding protein identified by proteomics as potential biomarkers for lupus nephritis.

Authors:  A Aggarwal; R Gupta; V S Negi; L Rajasekhar; R Misra; P Singh; V Chaturvedi; S Sinha
Journal:  Clin Exp Immunol       Date:  2017-02-23       Impact factor: 4.330

Review 3.  Accelerated atherosclerosis in systemic lupus erythematosus: role of proinflammatory cytokines and therapeutic approaches.

Authors:  Chary López-Pedrera; Maria Ángeles Aguirre; Nuria Barbarroja; Maria José Cuadrado
Journal:  J Biomed Biotechnol       Date:  2010-09-26

4.  Omics Screening for Pharmaceutical Efficacy and Safety in Clinical Practice.

Authors:  Andrew A Monte; Vasilis Vasiliou; Kennon J Heard
Journal:  J Pharmacogenomics Pharmacoproteomics       Date:  2012-03-16

5.  Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2.

Authors:  Amit Tripathi; Karen M Lammers; Simeon Goldblum; Terez Shea-Donohue; Sarah Netzel-Arnett; Marguerite S Buzza; Toni M Antalis; Stefanie N Vogel; Aiping Zhao; Shiqi Yang; Marie-Claire Arrietta; Jon B Meddings; Alessio Fasano
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-15       Impact factor: 11.205

Review 6.  Contributions of mass spectrometry-based proteomics to defining cellular mechanisms and diagnostic markers for systemic lupus erythematosus.

Authors:  Erik A Korte; Patrick M Gaffney; David W Powell
Journal:  Arthritis Res Ther       Date:  2012-02-20       Impact factor: 5.156

7.  A plasma proteomic approach in Rett syndrome: classical versus preserved speech variant.

Authors:  Alessio Cortelazzo; Roberto Guerranti; Claudio De Felice; Cinzia Signorini; Silvia Leoncini; Alessandra Pecorelli; Claudia Landi; Luca Bini; Barbara Montomoli; Claudia Sticozzi; Lucia Ciccoli; Giuseppe Valacchi; Joussef Hayek
Journal:  Mediators Inflamm       Date:  2013-12-23       Impact factor: 4.711

8.  Supporting data for the MS identification of distinct transferrin glycopeptide glycoforms and citrullinated peptides associated with inflammation or autoimmunity.

Authors:  A Rosal-Vela; A Barroso; E Giménez; S García-Rodríguez; V Longobardo; J Postigo; M Iglesias; A Lario; J Merino; R Merino; M Zubiaur; V Sanz-Nebot; J Sancho
Journal:  Data Brief       Date:  2016-01-11

9.  Proteomics-based identification of haptoglobin as a favourable serum biomarker for predicting long-term response to splenectomy in patients with primary immune thrombocytopenia.

Authors:  Chao-Xu Zheng; Zhuang-Qi Ji; Long-Juan Zhang; Qiong Wen; Liu-Hua Chen; Jun-Feng Yu; Dong Zheng
Journal:  J Transl Med       Date:  2012-10-07       Impact factor: 5.531

10.  Behavioral Deficits Are Accompanied by Immunological and Neurochemical Changes in a Mouse Model for Neuropsychiatric Lupus (NP-SLE).

Authors:  Yan Li; Amanda R Eskelund; Hua Zhou; David P Budac; Connie Sánchez; Maria Gulinello
Journal:  Int J Mol Sci       Date:  2015-07-03       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.